During Tuesday's Mad Money "Lightning Round", one caller asked Jim Cramer about a company by the name of Lexicon Pharmaceuticals (LXRX) : "I like companies like this," he responded. Let's check out the chart of this biopharmaceutical company that is using gene science.
More from Investing
I'd like to sound more positive, but this is all that was accomplished Monday.
Today's move has a good shot at breaking the nasty downtrend from the past three weeks.
With share prices turning softer, we need to reevaluate.